Inhibitors of protein prenylation 1999

Expert Opinion on Therapeutic Patents

Volumn 9, Issue 9, 1999, Pages 1263-1280

  Williams, T M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Antiproliferative; Cancer; Farnesyltransferase (FTase); Farnesyltransferase inhibitor (FTI); Protein prenylation

Indexed keywords

4 (8 CHLORO 5,6 DIHYDRO 11H BENZO[5,6]CYCLOHEPTA[1,2 B]PYRIDIN 11 YLIDENE) 1 (4 PYRIDYLACETYL)PIPERIDINE; FARNESYL TRANS TRANSFERASE; GGTI 286; GGTI 287; HERBACEOUS AGENT; PROTEIN FARNESYLTRANSFERASE INHIBITOR; SCH 59228; SCH 60677; SCH 66366; TIPIFARNIB; UNCLASSIFIED DRUG;

CANCER; CANCER THERAPY; CELL PROLIFERATION; CLINICAL TRIAL; COMPETITIVE INHIBITION; DRUG EFFECT; DRUG HALF LIFE; DRUG STRUCTURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPENIA; NONHUMAN; ONCOGENE K RAS; ORAL DRUG ADMINISTRATION; PATENT; PRENYLATION; REVIEW; THROMBOCYTOPENIA;

EID: 0032844397     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.9.9.1263     Document Type: Review

References (201)